Jianing Huang

Title: Innovations of Jianing Huang

Introduction

Jianing Huang is an accomplished inventor based in San Bruno, CA. He has made significant contributions to the field of biotechnology, particularly in the area of tumor necrosis factor signal transduction. With a total of 2 patents, his work has the potential to impact pharmacological research and development.

Latest Patents

Huang's latest patents include two notable inventions related to the human Receptor Interacting Protein (hRIP). The first patent describes hRIP as a human protein involved in tumor necrosis factor signal transduction. This invention encompasses nucleic acids that encode hRIP and methods for utilizing these compositions. Specifically, it includes hRIP-based in vitro binding assays and phosphorylation assays aimed at screening chemical libraries for lead compounds that could serve as pharmacological agents. The second patent reiterates similar themes, emphasizing the importance of hRIP in the same biological processes and its applications in drug discovery.

Career Highlights

Throughout his career, Jianing Huang has worked with prominent companies in the biotechnology sector, including Tularik Limited and Amgen Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research.

Collaborations

Huang has collaborated with notable professionals in his field, including Vijay R. Baichwal and Hailing Hsu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Jianing Huang's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in pharmacological research and therapeutic development.